Frontlight ResearchEarly access
What researchers published on Sjögren's disease
7,145 papers, newest first.
Showing 20 of 132
Randomised trialIanalumab for the Treatment of Patients with Sjögren's Disease.The New England journal of medicine
In plain wordsRead moreRead the paper on PubMedTrial result68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren's disease: a prospective case-control study.Rheumatology (Oxford, England)
Randomised trialRepurposing leflunomide and hydroxychloroquine to treat Sjögren's disease (RepurpSS-II): a randomised, double-blind, placebo-controlled, phase 2b trial.The Lancet. Rheumatology
In plain wordsRead moreRead the paper on PubMedRandomised trialInflammatory cytokines, autoantibodies and salivary gland function in Sjögren's syndrome: Effects of T. wilfordii as Hook F medical wine and tripterygium glycosides tablets.International journal of clinical pharmacology and therapeutics
In plain wordsRead moreRead the paper on PubMedRandomised trialLaser Acupuncture on the Management of Xerostomia in Sjögren's Disease: A Randomized Clinical Trial.Oral diseases
In plain wordsRead moreRead the paper on PubMedRandomised trialEfgartigimod in Sjögren's disease: a phase 2, randomised, placebo-controlled, parallel-group, double-blinded, proof-of-concept study (RHO).Annals of the rheumatic diseases
In plain wordsRead moreRead the paper on PubMedRandomised trialEffectiveness of a Biopsychosocial-Based Exercise Approach Delivered in Group and Individual Formats in Primary Sjögren Disease: A Randomized Controlled Trial.Archives of physical medicine and rehabilitation
In plain wordsRead moreRead the paper on PubMedRandomised trialLower magnitude of humoral response to recombinant herpes zoster vaccine in immunocompromised Sjögren's disease patients: evidence from a randomized double-blinded placebo-controlled trial.Seminars in arthritis and rheumatism
In plain wordsRead moreRead the paper on PubMedTrial resultEnhanced efficacy of 0.05% cyclosporine a combined with absorbable punctal plugs in Sjögren's syndrome-associated dry eye: a paired-eye clinical trial.Frontiers in medicine
In plain wordsRead moreRead the paper on PubMedRandomised trialEfficacy and safety of iguratimod in patients with primary Sjögren's syndrome: a multicentre randomised controlled trial.RMD open
In plain wordsRead moreRead the paper on PubMedTrial resultEvaluation of umbilical cord blood serum eye drops for severe dry eye in two distinct populations-Sjögren's syndrome and mustard gas-induced ocular injury: Protocol for a pilot randomized clinical trial.PloS one
Randomised trialEfficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial.Lancet (London, England)
Randomised trialProteins linked to type II interferon response in Sjögren's disease: novel indicators for disease monitoring and predicting treatment response to leflunomide and hydroxychloroquine combination therapy.Frontiers in immunology
Randomised trialEfficacy of topical mesenchymal stem cell exosome in Sjögren's syndrome-related dry eye: a randomized clinical trial.BMC ophthalmology
Trial resultA first-in-human, prospective pilot trial of umbilical cord-derived mesenchymal stem cell eye drops therapy for patients with refractory non-Sjögren's and Sjögren's syndrome dry eye disease.Stem cell research & therapy
Randomised trialProspective Sham-Controlled trial: acupuncture for symptom-relieving in patients with Sjögren's disease.Clinical rheumatology
Trial resultVarenicline Solution Nasal Spray for the Treatment of Dry Eye Disease in Sjogren's Disease: A Pilot Study.Clinical ophthalmology (Auckland, N.Z.)
Trial resultEvaluating the therapeutic potential of tofacitinib in Sjögren's disease: a comprehensive clinical and immunological assessment.Rheumatology (Oxford, England)
Randomised trialThe Effect of Autologous Serum Tears 50% on the Ocular Surface of Patients With Severe Dry Eye Disease due to Sjogren Syndrome: A Prospective, Double-Blind, Randomized, Controlled, Contralateral Eye Study.Cornea
Randomised trialAbatacept use for 24 weeks has a limited effect on salivary gland inflammation in Sjögren's disease patients.Clinical and experimental rheumatology